Home›Sucralfate

Sucralfate

Also known as: Carafate

Aluminum Complex

Route: Oral

Check Sucralfate Interactions →
24 interactions on record

Sucralfate has 24 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Ciprofloxacin, Cimetidine, Delafloxacin Meglumine. Patients taking Sucralfate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
24
Major
1
Moderate
23

Major (1)

  • Sucralfate + Ciprofloxacin— Concurrent administration may substantially decrease ciprofloxacin absorption, resulting in serum and urine levels consi…

Moderate (23)

  • Sucralfate + Cimetidine— Sucralfate reduces the bioavailability of cimetidine. Dosing cimetidine 2 hours before sucralfate eliminates the interac…
  • Sucralfate + Delafloxacin Meglumine— Sucralfate forms chelates with delafloxacin, substantially interfering with absorption and resulting in considerably low…
  • Sucralfate + Digoxin— Sucralfate reduces the bioavailability of digoxin. Dosing digoxin 2 hours before sucralfate eliminates the interaction.
  • Sucralfate + Furosemide— Simultaneous administration of sucralfate and furosemide may reduce natriuretic and antihypertensive effects. Separate i…
  • Sucralfate + Furosemide, Benzalkonium Chloride— Simultaneous administration of sucralfate and furosemide tablets may reduce the natriuretic and antihypertensive effects…
  • Sucralfate + Ketoconazole— Sucralfate reduces the bioavailability of ketoconazole. Monitor absorption when used concomitantly.
  • Sucralfate + L-Thyroxine— Sucralfate reduces the bioavailability of l-thyroxine. Separate dosing administration is recommended.
  • Sucralfate + Levofloxacin— Absorption of levofloxacin is decreased when tablets are taken within 2 hours, resulting in considerably lower systemic …
  • Sucralfate + Levothyroxine Sodium— May cause hypochlorhydria and affect intragastric pH, reducing levothyroxine absorption. Monitor patients appropriately.
  • Sucralfate + Macrolide Antibiotics— Sucralfate reduces the bioavailability of fluoroquinolone antibiotics. Dosing 2 hours before sucralfate eliminates the i…
  • Sucralfate + Moxifloxacin— Forms chelates with moxifloxacin, substantially decreasing absorption. Take moxifloxacin at least 4 hours before or 8 ho…
  • Sucralfate + Moxifloxacin Hydrochloride— Decreased moxifloxacin absorption due to chelate formation. Take moxifloxacin at least 4 hours before or 8 hours after s…
  • Sucralfate + Moxifloxacin Hydrochloride Tablets, 400 Mg— Sucralfate forms chelates with moxifloxacin, substantially interfering with absorption. Take moxifloxacin at least 4 hou…
  • Sucralfate + Naproxen— Concomitant administration can delay the absorption of naproxen.
  • Sucralfate + Norfloxacin— Sucralfate reduces the bioavailability of norfloxacin. Dosing norfloxacin 2 hours before sucralfate eliminates the inter…
  • Sucralfate + Ofloxacin— Sucralfate reduces the bioavailability of ofloxacin. Dosing ofloxacin 2 hours before sucralfate eliminates the interacti…
  • Sucralfate + Phenytoin— Sucralfate reduces the bioavailability of phenytoin. Separate dosing administration is recommended.
  • Sucralfate + Phenytoin Sodium— May decrease phenytoin serum levels; monitoring of phenytoin levels recommended.
  • Sucralfate + Quinidine— Sucralfate reduces the bioavailability of quinidine. Separate dosing administration is recommended.
  • Sucralfate + Ranitidine— Sucralfate reduces the bioavailability of ranitidine. Dosing ranitidine 2 hours before sucralfate eliminates the interac…
  • Sucralfate + Tetracycline— Sucralfate reduces the bioavailability of tetracycline. Separate dosing administration is recommended.
  • Sucralfate + Theophylline— Sucralfate reduces the bioavailability of theophylline. Separate dosing administration is recommended.
  • Sucralfate + Warfarin— Subtherapeutic prothrombin times reported with concomitant warfarin and sucralfate; however, clinical studies showed no …

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations